Who owns Plus Therapeutics Inc?
- Ticker: PSTV
- CUSIP Number: 72941h806
Tip: Access positions for across all investors
Analyze quarterly positions in Plus Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Plus Therapeutics stock
Who bought or sold Plus Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Capital Management | 305k | $1.3M | 100% | Jun 2026 |
|
| BlackRock | 96k | $420k | 100% | Jun 2026 |
|
| Geode Capital Management | 76k | $333k | 100% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 37k | $161k | 100% | Jun 2026 |
|
| Ashton Thomas Private Wealth | 34k | $150k | 100% | Jun 2026 |
|
| Citadel Advisors | 26k | $112k | 100% | Jun 2026 |
|
| Northern Trust | 16k | $68k | 100% | Jun 2026 |
|
| Virtu Financial | 15k | $67k | 100% | Jun 2026 |
|
| Hrt Financial | 12k | $50k | 100% | Jun 2026 |
|
| Wells Fargo & Company | 6.2k | $27k | 100% | Jun 2026 |
|
| Vanguard Global Advisers | 2.3k | $10k | 100% | Jun 2026 |
|
| Advisor Group Holdings | 2.0k | $8.7k | 100% | Jun 2026 |
|
| Tower Research Capital | 2.0k | $8.5k | 100% | Jun 2026 |
|
| Allied Private Wealth | 496.00 | $1.9k | 100% | Jun 2026 |
|
| UBS Group | 470.00 | $2.1k | 100% | Jun 2026 |
|
| SBI Securities | 251.00 | $1.1k | -91% | Jun 2026 |
|
| Barclays | 96.00 | $420.000000 | 100% | Jun 2026 |
|
| Mercer Global Advisors | 64.00 | $280.000000 | 100% | Jun 2026 |
|
| Caitong International Asset Management | 12.00 | $51.999600 | 100% | Jun 2026 |
|
| Global Retirement Partners | 4.00 | $17.000000 | 100% | Jun 2026 |
|